Design of Peptide Immunotherapies for MHC Class-II-Associated Autoimmune Disorders

被引:10
|
作者
Fridkis-Hareli, Masha [1 ]
机构
[1] ATR LLC, Worcester, MA 01606 USA
来源
CLINICAL & DEVELOPMENTAL IMMUNOLOGY | 2013年
关键词
AMINO-ACID COPOLYMERS; MYELIN BASIC-PROTEIN; T-CELL RESPONSES; REMITTING MULTIPLE-SCLEROSIS; ANTIGEN-PRESENTING CELLS; HISTOCOMPATIBILITY COMPLEX-MOLECULES; HLA-DR MOLECULES; RHEUMATOID-ARTHRITIS; GLATIRAMER ACETATE; EXPERIMENTAL ENCEPHALOMYELITIS;
D O I
10.1155/2013/826191
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Autoimmune disorders, that occur when autoreactive immune cells are induced to activate their responses against self-tissues, affect one percent of the world population and represent one of the top 10 leading causes of death. The major histocompatibility complex (MHC) is a principal susceptibility locus for many human autoimmune diseases, in which self-tissue antigens providing targets for pathogenic lymphocytes are bound to HLA molecules encoded by disease-associated alleles. In spite of the attempts to design strategies for inhibition of antigen presentation targeting the MHC-peptide/TCR complex via generation of blocking antibodies, altered peptide ligands (APL), or inhibitors of costimulatory molecules, potent therapies with minimal side effects have yet to be developed. Copaxone (glatiramer acetate, GA) is a random synthetic amino acid copolymer that reduces the relapse rate by about 30% in relapsing-remitting multiple sclerosis (MS) patients. Based on the elucidated binding motifs of Copaxone and of the anchor residues of the immunogenic myelin basic protein (MBP) peptide to HLA-DR molecules, novel copolymers have been designed and proved to be more effective in suppressing MS-like disease in mice. In this report, we describe the rationale for design of second-generation synthetic random copolymers as candidate drugs for a number of MHC class-II-associated autoimmune disorders.
引用
收藏
页数:9
相关论文
共 37 条
  • [21] Enhanced Detection of Antigen-Specific CD4+ T Cells Using Altered Peptide Flanking Residue Peptide-MHC Class II Multimers
    Holland, Christopher J.
    Dolton, Garry
    Scurr, Martin
    Ladell, Kristin
    Schauenburg, Andrea J.
    Miners, Kelly
    Madura, Florian
    Sewell, Andrew K.
    Price, David A.
    Cole, David K.
    Godkin, Andrew J.
    JOURNAL OF IMMUNOLOGY, 2015, 195 (12) : 5827 - 5836
  • [22] Both qualitative and quantitative genetic variation of MHC class II molecules may influence susceptibility to autoimmune diseases: The case of endemic pemphigus foliaceus
    Piovezan, Bruno Zagonel
    Petzl-Erler, Maria Luiza
    HUMAN IMMUNOLOGY, 2013, 74 (09) : 1134 - 1140
  • [23] Heligmosomoides polygyrus infection is associated with lower MHC class II gene expression in Apodemus flavicollis: Indication for immune suppression?
    Axtner, Jan
    Sommer, Simone
    INFECTION GENETICS AND EVOLUTION, 2011, 11 (08) : 2063 - 2071
  • [24] SOLUBLE HLA-DR MOLECULES IN PATIENTS WITH HLA CLASS-II VERSUS CLASS-I ASSOCIATED DISORDERS
    WEYAND, CM
    JENDRO, M
    GORONZY, JJ
    AUTOIMMUNITY, 1991, 8 (04) : 281 - 287
  • [25] Aire is not essential for regulating neuroinflammatory disease in mice transgenic for human autoimmune-diseases associated MHC class II genes HLA-DR2b and HLA-DR4
    Nalawade, Saisha A.
    Ji, Niannian
    Raphael, Itay
    Pratt, Andrew, III
    Kraig, Ellen
    Forsthuber, Thomas G.
    CELLULAR IMMUNOLOGY, 2018, 331 : 38 - 48
  • [26] Role of major histocompatibility complex class II expression by non-hematopoietic cells in autoimmune and inflammatory disorders: facts and fiction
    Duraes, F. V.
    Thelemann, C.
    Sarter, K.
    Acha-Orbea, H.
    Hugues, S.
    Reith, W.
    TISSUE ANTIGENS, 2013, 82 (01): : 1 - 15
  • [27] Oxazole-modified glycopeptides that target arthritis-associated class II MHC Aq and DR4 proteins
    Andersson, Ida E.
    Batsalova, Tsvetelina
    Dzhambazov, Balik
    Edvinsson, Lotta
    Holmdahl, Rikard
    Kihlberg, Jan
    Linusson, Anna
    ORGANIC & BIOMOLECULAR CHEMISTRY, 2010, 8 (13) : 2931 - 2940
  • [28] Genome-Wide Analysis Identifies a Quantitative Trait Locus in the MHC Class II Region Associated with Generalized Vitiligo Age of Onset
    Jin, Ying
    Birlea, Stanca A.
    Fain, Pamela R.
    Gowan, Katherine
    Riccardi, Sheri L.
    Holland, Paulene J.
    Bennett, Dorothy C.
    Herbstman, Deborah M.
    Wallace, Margaret R.
    McCormack, Wayne T.
    Kemp, E. Helen
    Gawkrodger, David J.
    Weetman, Anthony P.
    Picardo, Mauro
    Leone, Giovanni
    Taieb, Alain
    Jouary, Thomas
    Ezzedine, Khaled
    van Geel, Nanny
    Lambert, Jo
    Overbeck, Andreas
    Spritz, Richard A.
    JOURNAL OF INVESTIGATIVE DERMATOLOGY, 2011, 131 (06) : 1308 - 1312
  • [29] The relationship between predicted peptide–MHC class II affinity and T-cell activation in a HLA-DRβ1*0401 transgenic mouse model
    Jonathan A Hill
    Dequn Wang
    Anthony M Jevnikar
    Ewa Cairns
    David A Bell
    Arthritis Res Ther, 5
  • [30] The relationship between predicted peptide-MHC class II affinity and T-cell activation in a HLA-DRβ1*0401 transgenic mouse model
    Hill, JA
    Wang, DQ
    Jevnikar, AM
    Cairns, E
    Bell, DA
    ARTHRITIS RESEARCH & THERAPY, 2003, 5 (01) : R40 - R48